GAM
XLRN

Gotham Asset Management’s Acceleron Pharma XLRN Stock Holding History

Gotham Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,923
Closed -$442K – 1241
2020
Q1 		$442K Buy
+4,923
New +$383K 0.01% 742
2016
Q3 		– Sell
-30,547
Closed -$1.04M – 1087
2016
Q2 		$1.04M Buy
+30,547
New +$993K 0.01% 625

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Gotham Asset Management's XLRN Position: Q2 2020 in Review

Gotham Asset Management sold out of Acceleron Pharma (XLRN) in Q2 2020, closing a stake of 4,923 shares — an estimated $442K sold.

Gotham Asset Management first reported a position in XLRN in Q2 2016 and held it in 2 quarters. The position peaked at $1.04M in Q2 2016. 242 funds tracked by Wall St. Rank hold XLRN as of Q2 2020.

  • Gotham Asset Management reported no remaining Acceleron Pharma position as of Q2 2020 after selling out during the quarter.
  • Gotham Asset Management sold 4,923 Acceleron Pharma shares in Q2 2020, an estimated $442K.
  • Gotham Asset Management first reported a position in Acceleron Pharma in Q2 2016 and held it in 2 quarters.
  • Gotham Asset Management's Acceleron Pharma position peaked at $1.04M in Q2 2016.
  • 242 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2020.

Based on Gotham Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.